NCT02072954 - Bioequivalence Fasting Study in Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

June 30, 2014

Conditions

Schizophrenia

Interventions

DRUG

Asenapine Sublingual Tablets 10 mg

White to off-white, round, uncoated,unscored, flat-faced radius edge tablet. Debossed with A on one side and 17 on the other side

DRUG

Asenapine Sublingual Tablets 10 mg

"Round, white to off-white sublingual tablets, with 10 on one side within a circle"

Trial Locations (2)

Shri Hatkesh Healthcare Foundation, Jūnāgadh

Divyam Hospital, Surat